Inflammatory Bowel Disease and Statins

Por V. V. Genkel, I. I. Shaposhnik
Publicado em 2020-04-01

Antitumor effects of cardiovascular drugs

Por I. I. Shaposhnik, V. V. Genkel
Publicado em 2020-10-01

Features of diagnosis and treatment of patients with stable coronary artery disease at initially normal arterial pressure

Por I. I. Shaposhnik, N. V. Vvedenskaya
Publicado em 2018-09-01

Clinical variants, outcomes and prognosis of hypertrophic non-obstructive cardiomyopathy: results of long-term follow-up

Por D. V. Bogdanov, I. I. Shaposhnik
Publicado em 2019-11-01

The prognostic value of various markers of lower limb atherosclerotic lesions in patients with high and very high cardiovascular risk

Por V. V. Genkel, I. I. Shaposhnik
Publicado em 2019-06-01

Regional Arterial Stiffness in Patients with Inflammatory Bowel Disease

Por V. V. Genkel, R. G. Portnova, T. V. Antipina, I. I. Shaposhnik
Publicado em 2019-06-01

Prognostic significance of atherosclerosis of one or two vascular systems in patients with high and very high cardiovascular risk

Por V. V. Genkel, A. S. Kuznetsova, E. V. Lebedev, I. I. Shaposhnik
Publicado em 2021-03-01

Experience in teaching deontology to students by managing patients with cardiovascular diseases

Por I. I. Shaposhnik, D. V. Bogdanov, V. V. Genkel, M. I. Kolyadich
Publicado em 2020-09-01

Prognostic significance of moderate cognitive impairment in patients at high and very high cardiovascular risk

Por V. V. Henkel, A. S. Kuznetsova, A. O. Salashenko, E. V. Lebedev, I. I. Shaposhnik
Publicado em 2019-12-01

Increase in high-sensitive C-reactive protein as a marker of polyvascular disease in patients with cardiovascular diseases

Por V. V. Genkel, A. S. Kuznetcova, V. A. Sumerkina, A. O. Salashenko, E. V. Lebedev, I. I. Shaposhnik
Publicado em 2019-10-01

Value of duplex ultrasound of carotid and lower extremity arteries in the restratification of cardiovascular risk and initiation of lipid-lowering therapy

Por V. V. Genkel, A. S. Kuznetsova, L. R. Pykhova, E. V. Lebedev, A. O. Salashenko, I. I. Shaposhnik
Publicado em 2022-02-01

Ultrasound examination of achilles tendons in patients with familial hypercholesterolemia

Por V. V. Genkel, M. I. Kolyadich, E. V. Lebedev, A. S. Kuznetsova, R. G. Portnova, I. I. Shaposhnik
Publicado em 2018-09-01

Atherosclerosis of peripheral arteries in patients with coronary artery disease and type 2 diabetes mellitus

Por V V Genkel, A O Salashenko, T N Shamaeva, V A Sumerkina, K V Nikushkina, I I Shaposhnik
Publicado em 2019-10-01

Association of the increased circulating CD62LloCXCR4hi neutrophil count with carotid atherosclerosis

Por I. I. Dolgushin, V. V. Genkel, I. L. Baturina, I. V. Emelyanov, A. Y. Savochkina, I. I. Shaposhnik
Publicado em 2021-05-01

Differentiated approach to the use of optimal medical therapy in patients with various clinical forms of stable ischemic heart disease

Por I. I. Shaposhnik, V. I. Karnot, T. M. Karandasova, O. F. Bannikova, O. G. Bocharova, L. V. Belolipetskaya, E. V. Lebedev, A. O. Salashenko
Publicado em 2019-01-01

Interactions between immunosuppressor neutrophiles, innate and adaptive immunity indexes in the patients with subclinical atherosclerosis

Por I. I. Dolgushi, V. V. Genkel, I. L. Baturina, A. Yu. Savochkina, A. A. Minasova, K. V. Nikushkina, L. R. Pykhova, A. S. Kuznetcova, I. I. Shaposhnik
Publicado em 2022-04-01

Emergency care in a sudden individually significant blood pressure increase without clinically overt target organ damage: rationale for captopril use. Expert Council opinion

Por S. N. Tereshchenko, G. P. Arutyunov, A. S. Galyavich, N. I. Gaponova, S. R. Gilyarevsky, D. V. Duplyakov, I. V. Zhirov, V. V. Skibitskii, O. N. Tkacheva, I. I. Shaposhnik
Publicado em 2020-03-01

Practical efficacy and safety of Konsilar D24 in patients with hypertension: data from the KONSONANS program

Por A. O. Konradi, A. S. Galyavich, V. V. Kashtalap, Yu. M. Lopatin, N. P. Lyamina, S. V. Nedogoda, A. O. Nedoshivin, G. I. Nechaeva, L. G. Ratova, I. I. Shaposhnik
Publicado em 2021-10-01

Existing problems and new possibilities in the treatment of dyslipidemia Joint Conclusion Based on the Results of the Expert Council

Por M. V. Ezhov, V. V. Kukharchuk, I. V. Sergienko, N. M. Akhmedzhanov, M. I. Voevoda, V. S. Gurevich, V. V. Kashtalap, V. O. Konstantinov, V. V. Skibitsky, I. I. Shaposhnik
Publicado em 2021-03-01

The Role of Red Yeast Rice Based Preparations for Non-Pharmacological Correction of Dyslipidemia in Patients with Low and Moderate Cardiovascular Risk (Expert Opinion)

Por M. V. Ezhov, A. Catapano, C. Escobar, V. V. Kukharchuk, M. I. Voevoda, O. M. Drapkina, S. A. Shalnova, A. V. Starodubova, V. S. Gurevich, I. I. Shaposhnik, O. O. Bolshakova, O. S. Oynotkinova, A. S. Alieva
Publicado em 2020-03-01